Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer’s Disease
Home
>
News
>
Oligomerix Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer’s Disease
Print
Oligomerix
>
News
>
Oligomerix Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer’s Disease
Oligomerix Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer’s Disease
Post navigation
Previous Post
Oligomerix funded by the Alzheimer’s Drug Discovery Foundation to evaluate compounds active against tau oligomers, a novel target for therapeutic development
Next Post
Oligomerix Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
